Shufen Zhao
-
- MicroRNA in disease regulation 5
- Cancer, Lipids, and Metabolism 3
-
- Cancer Immunotherapy and Biomarkers 3
-
- Ferroptosis and cancer prognosis 6
- Gastric Cancer Management and Outcomes 4
-
- RNA modifications and cancer 10
- Epigenetics and DNA Methylation 4
-
- Autophagy in Disease and Therapy 4
- Co-authors
- Libin SunWensheng QiuJing GuoShasha WangWeiwei QiWenqian LiYuqi ZhangJing Lv
- Journals
- Frontiers in Immunology (4 papers)Journal of Clinical Oncology (2 papers)Clinical & Translational Oncology (1 paper)
- Partner nations
- China
In The Last Decade
Shufen Zhao
28 papers receiving 315 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 106
- Otorhinolaryngology 22
- Immunology and Allergy 19
- Oncology 83
- Pulmonary and Respiratory Medicine 97
Countries citing papers authored by Shufen Zhao
This map shows the geographic impact of Shufen Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufen Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufen Zhao more than expected).
Fields of papers citing papers by Shufen Zhao
This network shows the impact of papers produced by Shufen Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufen Zhao. The network helps show where Shufen Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shufen Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 23 | |
| 10 | 2021 | 13 | |
| 11 | 2020 | 28 | |
| 12 | 2019 | 1 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 30 | |
| 15 | 2018 | 3 | |
| 16 | 2017 | 15 | |
| 17 | 2016 | 6 | |
| 18 | 2016 | 4 | |
| 19 | 2016 | 10 | |
| 20 | 2016 | 23 |
About Shufen Zhao
Shufen Zhao is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Allergy, Oncology and Molecular Biology, having authored 30 papers that have together received 316 indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Ferroptosis and cancer prognosis (6 papers), MicroRNA in disease regulation (5 papers), Epigenetics and DNA Methylation (4 papers), Autophagy in Disease and Therapy (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer, Lipids, and Metabolism (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (106 citations), Otorhinolaryngology (22 citations), Immunology and Allergy (19 citations), Oncology (83 citations) and Pulmonary and Respiratory Medicine (97 citations). Shufen Zhao has collaborated with scholars based in China. Frequent co-authors include Libin Sun, Wensheng Qiu, Wensheng Qiu, Jing Guo, Shasha Wang, Weiwei Qi, Wenqian Li, Yuqi Zhang, Jing Lv and Yuanqing Zhou. Their work appears in journals such as Frontiers in Immunology, Journal of Clinical Oncology, Clinical & Translational Oncology, Molecular Genetics and Genomics and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.